CNE1000050F4
CNE1000050F4
SHANGHAI YIZHONG PHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 316.076.818 | 173.532.721 | 82.1% |
| Cost of Revenue | 53.367.631 | 13.332.457 | 300.3% |
| Gross Profit | 262.709.187 | 160.200.264 | 64.0% |
| 212.750.137 | 179.961.082 | 18.2% | |
| Operating Income | 49.959.049 | -19.760.818 | 352.8% |
| Pretax Income | 61.149.325 | 4.817.201 | 1169.4% |
| Net Income Common Stockholders | 64.555.772 | 6.975.283 | 825.5% |
| -- | -- | -- | |
| -- | -- | -- |